These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2181087)

  • 1. Fibrocystic breast disease. An update and review.
    Norwood SL
    J Obstet Gynecol Neonatal Nurs; 1990; 19(2):116-21. PubMed ID: 2181087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral contraceptive use and fibrocystic breast disease of different histologic classifications.
    Hsieh CC; Crosson AW; Walker AM; Trapido EJ; MacMahon B
    J Natl Cancer Inst; 1984 Feb; 72(2):285-90. PubMed ID: 6582316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. THE ROLE OF E2/P RATIO IN THE ETIOLOGY OF FIBROCYSTIC BREAST DISEASE, MASTALGIA AND MASTODYNIA.
    Brkić M; Vujović S; Ivović M; Tančić Gajić M; Marina L; Franić Ivanišević M; Franić D
    Acta Clin Croat; 2018 Dec; 57(4):756-761. PubMed ID: 31168213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonassociation of caffeine and fibrocystic breast disease.
    Levinson W; Dunn PM
    Arch Intern Med; 1986 Sep; 146(9):1773-5. PubMed ID: 3530165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theophylline and fibrocystic breast disease.
    Hindi-Alexander MC; Zielezny MA; Montes N; Bullough B; Middleton E; Rosner DH; London WM
    J Allergy Clin Immunol; 1985 Jun; 75(6):709-15. PubMed ID: 4008800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nutritional profile of women with fibrocystic breast disease.
    Vobecky J; Simard A; Vobecky JS; Ghadirian P; Lamothe-Guay M; Falardeau M
    Int J Epidemiol; 1993 Dec; 22(6):989-99. PubMed ID: 8144312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case-control study of fibrocystic breast disease.
    Simard A; Vobecky J; Vobecky JS; Ghadirian P; Lamothe-Guay M; Falardeau M
    Rev Epidemiol Sante Publique; 1993; 41(1):84-9. PubMed ID: 8465069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrocystic breast disease: pathophysiology, pathomorphology, clinical picture, and management.
    Vorherr H
    Am J Obstet Gynecol; 1986 Jan; 154(1):161-79. PubMed ID: 3511705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrocystic change and fibrocystic disease of the breast.
    Drukker BH; deMendonca WC
    Obstet Gynecol Clin North Am; 1987 Sep; 14(3):685-702. PubMed ID: 3323971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycystic ovary syndrome and fibrocystic breast disease: is there any association?
    Gumus II; Koktener A; Dogan D; Turhan NO
    Arch Gynecol Obstet; 2009 Aug; 280(2):249-53. PubMed ID: 19123007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral contraceptive use and fibrocystic breast disease among pre- and postmenopausal women.
    Berkowitz GS; Kelsey JL; LiVolsi VA; Holford TR; Merino MJ; Ort S; O'Connor TZ; Goldenberg IS; White C
    Am J Epidemiol; 1984 Jul; 120(1):87-96. PubMed ID: 6741927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary and other risk factors in women having fibrocystic breast conditions with and without concurrent breast cancer: a nested case-control study in Shanghai, China.
    Li W; Ray RM; Lampe JW; Lin MG; Gao DL; Wu C; Nelson ZC; Fitzgibbons ED; Horner N; Hu YW; Shannon J; Satia JA; Patterson RE; Stalsberg H; Thomas DB
    Int J Cancer; 2005 Jul; 115(6):981-93. PubMed ID: 15723298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic Response to Omega-3 Fatty Acids and Vitamin E Co-Supplementation in Patients with Fibrocystic Breast Disease: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Mirhashemi SM; Sahmani M; Salehi B; Zavar Reza J; Taghizadeh M; Moussavi N; Badehnoosh B; Asemi Z
    Arch Iran Med; 2017 Aug; 20(8):466-473. PubMed ID: 28846009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Danazol alters mitochondria metabolism of fibrocystic breast Mcf10A cells.
    Irgebay Z; Yeszhan B; Sen B; Tuleukhanov S; Brooks AD; Sensenig R; Orynbayeva Z
    Breast; 2017 Oct; 35():55-62. PubMed ID: 28649033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrocystic breast nondisease.
    Vorherr H
    N Engl J Med; 1985 May; 312(19):1258-9. PubMed ID: 3990719
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytogenetic changes in benign proliferative and nonproliferative lesions of the breast.
    Lundin CP; Mertens F; Rizou H; Idvall I; Georgiou G; Ingvar C; Pandis N
    Cancer Genet Cytogenet; 1998 Dec; 107(2):118-20. PubMed ID: 9844605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for fibrocystic breast disease and its histopathologic components.
    Berkowitz GS; Kelsey JL; LiVolsi VA; Holford TR; Merino MJ; Ort S; O'Connor TZ; White C
    J Natl Cancer Inst; 1985 Jul; 75(1):43-50. PubMed ID: 3859695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sounding board. Fibrocystic "disease" of the breast--a nondisease?
    Love SM; Gelman RS; Silen W
    N Engl J Med; 1982 Oct; 307(16):1010-4. PubMed ID: 7110289
    [No Abstract]   [Full Text] [Related]  

  • 19. Caffeine consumption and fibrocystic breast disease: a case-control epidemiologic study.
    Boyle CA; Berkowitz GS; LiVolsi VA; Ort S; Merino MJ; White C; Kelsey JL
    J Natl Cancer Inst; 1984 May; 72(5):1015-9. PubMed ID: 6585579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age at first birth and breast atypia.
    Hsieh CC; Walker AM; Trapido EJ; Crosson AW; MacMahon B
    Int J Cancer; 1984 Mar; 33(3):309-12. PubMed ID: 6698636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.